nintedanib 100 MG

RxCUI
1592738
RxNorm name
nintedanib 100 MG
Term type
SCDC
Status
Active
Updated
2026-10-15 15:43:47

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122014
Active start
122014
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
100 MG / 1 EACHnintedanib

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
nintedanib1592737

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRnintedanib 100 MG1NAMES
RxNorm Namenintedanib 100 MG1NAMES
TTYSCDC1ATTRIBUTES
RxCUI15927381CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCL01EXOther protein kinase inhibitorsATC1-4nintedanib
FDASPLN0000175605Kinase InhibitorEPChas_epcnintedanib
FDASPLN0000175076Protein Kinase InhibitorsMOAhas_moanintedanib
MEDRTD007211IndolesCHEMhas_ingredientnintedanib
MEDRTD054990Idiopathic Pulmonary FibrosisDISEASEmay_treatnintedanib
MEDRTN0000020000Receptor Tyrosine Kinase InhibitorsMOAhas_moanintedanib
MEDRTN0000175678Decreased Endothelial ProliferationPEhas_penintedanib

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSTRENGTH100 MG